基于全面的生物信息学分析识别HOXB9,用于预测头部和部状细胞癌的预后

Juanjuan Li1, Hong Ran1,2, Xiaoxia Zeng1

  • 1Department of Otorhinolaryngology, Longgang Otorhinolaryngology Hospital & Shenzhen Key Laboratory of Otorhinolaryngology, Shenzhen Institute of Otorhinolaryngology, Shenzhen, Guangdong, China.

Medicine
|September 1, 2023
PubMed
概括

在头部和部平状细胞癌 (HNSCC) 中,HOXB9的调节升高,与恶性瘤增加和更差的预后相关. 该基因影响免疫细胞透,表明HOXB9是HNSCC.的潜在预后生物标志物和治疗点.